Use of mycophenolate in ANCA-associated renal vasculitis: 13 years of experience at a university hospital

Abstract

In conclusion, in our patients with rAAV, MF demonstrated to be an effective and well-tolerated option for maintenance treatment. As an induction treatment, MF seems to be similar to CYC for patients with moderate renal failure in the diagnosis.